Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: MOLECULAR EXPRESS, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-09-01 to 2027-08-31
Current total value of award: $2999352
Description: VESIVAX TLR7 FORMULA